NALGOLEN FORTE
Natural health product licensed in Canada
- Licence holder
- PHARCON Inc.
- NPN or DIN-HM
- 80070468
- Status
- Active licence
- Licence date
- 20 June 2016
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| DL-camphre | 8 Pour cent |
| Huile Essentielle de feuille d'Eucalyptus Globulus Source : Eucalyptus Globulus - leaves | 1 Pour cent |
| 2-hydroxybenzoate de méthyle Source : Gaultheria procumbens - feuille | 15 Pour cent |
| l-Menthol | 8 Pour cent |
Non-medicinal ingredients
Alcool éthylique, Lécithine, Polyoxyl 35 Castor Oil, Extrait de feuille de Salvia officinalis (sauge), Laneth-16, Glycérine, Trolamine, Essence de lemon-grass, Acétate de dl-alpha tocophéryle, Polymère croisé d'acrylates/acrylate d'alkyle en C10 à 30, Huile de coco fractionnée, Succinate de d-alpha-tocophéryle, Sorbate de potassium, Eau purifiée, Edetate Disodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12 years | minimum: 1 millilitre ; maximum: 3 millilitre | minimum: 1 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Temporarily relieves aches and pains of muscles and joints associated with simple backache, lumbago, strains and sprains (involving muscles, tendons, and/or ligaments), and arthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80070468
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.